Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Anna Orani"'
Autor:
Irene Guarnori, Daniele Prati, Manuela Gatti, Chiara Molteni, Roberto Rossotti, Barbara Foglieni, Anna Orani, Ennio La Russa
Publikováno v:
Journal of Medical Virology. 83:1493-1498
Migratory processes have caused changes in human immunodeficiency virus (HIV) epidemiology and non-B subtypes are now playing an increasing role. In a cohort of 553 HIV-infected outpatients tested to identify non-B isolates, the largest group consist
Autor:
Anna Orani, Antonio Di Biagio, Claudio Viscoli, Raffaella Rosso, Roberto Rossotti, Laura Ambra Nicolini, Fulvio Adorni
Publikováno v:
Current drug safety
6 (2011): 138–144. doi:10.2174/157488611797579339
info:cnr-pdr/source/autori:Rosso R.; Rossotti R.; Di Biagio A.; Nicolini L.; Adorni F.; Orani A.; Viscoli C./titolo:Nevirapine-based regimens in routine clinical settings: Results from a large italian cohort of HIV-1 infected adults/doi:10.2174%2F157488611797579339/rivista:Current drug safety (Print)/anno:2011/pagina_da:138/pagina_a:144/intervallo_pagine:138–144/volume:6
6 (2011): 138–144. doi:10.2174/157488611797579339
info:cnr-pdr/source/autori:Rosso R.; Rossotti R.; Di Biagio A.; Nicolini L.; Adorni F.; Orani A.; Viscoli C./titolo:Nevirapine-based regimens in routine clinical settings: Results from a large italian cohort of HIV-1 infected adults/doi:10.2174%2F157488611797579339/rivista:Current drug safety (Print)/anno:2011/pagina_da:138/pagina_a:144/intervallo_pagine:138–144/volume:6
We assessed the safety and efficacy of different nevirapine-based regimens in patients starting this drug in a large cohort of Caucasian subjects during the 1999-2007 periods. Methods. A retrospective database review of all patients receiving nevirap
Autor:
Irene Guarnori, Daniele Prati, Roberto Rossotti, M. Spreafico, Davide Rossi, L. Raffaele, Jean-Pierre Allain, Barbara Foglieni, Anna Orani, Alessandra Berzuini, Daniel Candotti
Publikováno v:
Transfusion. 51:719-730
BACKGROUND: Nucleic acid testing (NAT)-based methods for the detection and quantification of human immunodeficiency virus Type 1 (HIV-1) RNA are used to increase transfusion safety and to diagnose and manage HIV-1-infected patients. We describe a nov
Autor:
Ada Bertoli, E. Raise, Federica Forbici, A. Poggio, Michela Violin, Carlo Federico Perno, Mauro Moroni, Gioacchino Angarano, Pasquale Narciso, Patrizio Pezzotti, Antonella d'Arminio Monforte, Claudio Arici, Giuseppe Ippolito, Alfredo Scalzini, Guido Facchi, Anna Orani, Claudia Balotta, Alessandro Cozzi-Lepri
Publikováno v:
Antiviral Therapy. 6:195-198
Autor:
Barbara, Foglieni, Daniel, Candotti, Irene, Guarnori, Livia, Raffaele, Alessandra, Berzuini, Marta, Spreafico, Anna, Orani, Roberto, Rossotti, Davide, Rossi, Jean-Pierre, Allain, Daniele, Prati
Publikováno v:
Transfusion. 51(4)
Nucleic acid testing (NAT)-based methods for the detection and quantification of human immunodeficiency virus Type 1 (HIV-1) RNA are used to increase transfusion safety and to diagnose and manage HIV-1-infected patients. We describe a novel HIV-1 rec
Autor:
Joseph Scherer, Philippa Easterbrook, Laurence Weiss, Michael Kraft, Kathleen Squires, Sharon Walmsley, Anna Orani
Publikováno v:
AIDS (London, England). 23(3)
Gender-related differences in the efficacy and safety of ritonavir-boosted tipranavir [tipranavir/ritonavir (TPV/r) 500/200 mg twice daily (b.i.d.)] were evaluated in a subanalysis of the Randomized Evaluation of Strategic Intervention in Multidrug R
Autor:
Carmine Tinelli, Franco Maggiolo, A. Manzoni, Carlo Torti, Fredy Suter, Anna Orani, Giampiero Carosi, Giuseppe Paraninfo, Andrea Patroni, Policlinico S. Matteo, Lorenzo Minoli, Claudio Arici, Piera Pierotti, Nicoletta Ladisa, Laura Sighinolfi
Publikováno v:
The Journal of antimicrobial chemotherapy. 56(1)
This retrospective longitudinal cohort study compared the virological and immunological responses to highly active antiretroviral therapy containing either efavirenz or lopinavir/ritonavir in previously antiretroviral-naive HIV-infected patients.A to
Autor:
Francesco Mazzotta, Paolo Maggi, Filippo Castelnuovo, Carlo Torti, Francesca Moretti, Sergio Lo Caputo, Carmine Tinelli, Valeria Micheli, Nicoletta Ladisa, Anna Orani, Mario Regazzi, Andrea Patroni, Andrea Antinori, Eugenia Quiros-Roldan, Giampiero Carosi, Simona Di Giambenedetto, Paola Villani, Andrea De Luca
Background. It is not well defined whether concentration-controlled intervention (CCI) and rules-based human immunodeficiency virus (HIV) type 1 genotype drug-resistance interpretation (GI) or virtual phenotype drug-resistance interpretation (VPI) ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84ecad460c0a53a1dc47dd58276980f7
http://hdl.handle.net/11379/29133
http://hdl.handle.net/11379/29133
Autor:
Roberto Rossotti, Alessia Uglietti, Francesca Sabbatini, Cristina Gervasoni, Anna Orani, Eugenia Gabrielli, Raffaella Rosso, Valerio Rosso
Publikováno v:
Journal of Telemedicine and Telecare. 18:239-240
Autor:
Fredy Suter, Angelo Pan, Anna Orani, Giampiero Carosi, Franco Maggiolo, Francesco Mazzotta, Gian Marco Vigevani, Carmine Tinelli, Francesco Castelli, Renato Maserati, Massimo Andreoni
To compare in a real clinical setting the largely unknown midterm clinical effectiveness of two protease inhibitor (PI)-based highly active antiretroviral therapy (HAART) regimens with different potency and tolerability profiles in naïve patients.Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::458d2aa77eb9d6c83ca0d00f871c4384
http://hdl.handle.net/11379/1056
http://hdl.handle.net/11379/1056